BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 33965440)

  • 1. Exploiting the metabolic energy demands of drug efflux pumps provides a strategy to overcome multidrug resistance in cancer.
    Gao X; Aguanno D; Board M; Callaghan R
    Biochim Biophys Acta Gen Subj; 2021 Aug; 1865(8):129915. PubMed ID: 33965440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The anti-estrogen receptor drug, tamoxifen, is selectively Lethal to P-glycoprotein-expressing Multidrug resistant tumor cells.
    Bakadlag R; Limniatis G; Georges G; Georges E
    BMC Cancer; 2023 Jan; 23(1):24. PubMed ID: 36609245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isopetasin and S-isopetasin as novel P-glycoprotein inhibitors against multidrug-resistant cancer cells.
    Abdelfatah S; Böckers M; Asensio M; Kadioglu O; Klinger A; Fleischer E; Efferth T
    Phytomedicine; 2021 Jun; 86():153196. PubMed ID: 32229058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multidrug resistance: retrospect and prospects in anti-cancer drug treatment.
    Pérez-Tomás R
    Curr Med Chem; 2006; 13(16):1859-76. PubMed ID: 16842198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SERCA and P-glycoprotein inhibition and ATP depletion are necessary for celastrol-induced autophagic cell death and collateral sensitivity in multidrug-resistant tumor cells.
    Xu SW; Law BYK; Qu SLQ; Hamdoun S; Chen J; Zhang W; Guo JR; Wu AG; Mok SWF; Zhang DW; Xia C; Sugimoto Y; Efferth T; Liu L; Wong VKW
    Pharmacol Res; 2020 Mar; 153():104660. PubMed ID: 31982489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P-glycoprotein (ABCB1) modulates collateral sensitivity of a multidrug resistant cell line to verapamil.
    Laberge RM; Ambadipudi R; Georges E
    Arch Biochem Biophys; 2009 Nov; 491(1-2):53-60. PubMed ID: 19772851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folic Acid-Modified Nanoerythrocyte for Codelivery of Paclitaxel and Tariquidar to Overcome Breast Cancer Multidrug Resistance.
    Zhong P; Chen X; Guo R; Chen X; Chen Z; Wei C; Li Y; Wang W; Zhou Y; Qin L
    Mol Pharm; 2020 Apr; 17(4):1114-1126. PubMed ID: 32176509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. γ-Tocotrienol reverses multidrug resistance of breast cancer cells through the regulation of the γ-Tocotrienol-NF-κB-P-gp axis.
    Ding Y; Fan J; Fan Z; Zhang K
    J Steroid Biochem Mol Biol; 2021 May; 209():105835. PubMed ID: 33556581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. β-carotene reverses multidrug resistant cancer cells by selectively modulating human P-glycoprotein function.
    Teng YN; Sheu MJ; Hsieh YW; Wang RY; Chiang YC; Hung CC
    Phytomedicine; 2016 Mar; 23(3):316-23. PubMed ID: 26969385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Caffeic Acid Attenuates Multi-Drug Resistance in Cancer Cells by Inhibiting Efflux Function of Human P-glycoprotein.
    Teng YN; Wang CCN; Liao WC; Lan YH; Hung CC
    Molecules; 2020 Jan; 25(2):. PubMed ID: 31936160
    [No Abstract]   [Full Text] [Related]  

  • 11. Sweat but no gain: inhibiting proliferation of multidrug resistant cancer cells with "ersatzdroges".
    Kam Y; Das T; Tian H; Foroutan P; Ruiz E; Martinez G; Minton S; Gillies RJ; Gatenby RA
    Int J Cancer; 2015 Feb; 136(4):E188-96. PubMed ID: 25156304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of function of three ABC drug transporters, P-glycoprotein (ABCB1), mitoxantrone resistance protein (ABCG2) and multidrug resistance protein 1 (ABCC1) by tetrahydrocurcumin, a major metabolite of curcumin.
    Limtrakul P; Chearwae W; Shukla S; Phisalphong C; Ambudkar SV
    Mol Cell Biochem; 2007 Feb; 296(1-2):85-95. PubMed ID: 16960658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulation of ABCB1 by collateral sensitivity drugs reverses multidrug resistance and up-regulates enolase I.
    Limniatis G; Georges E
    J Biochem; 2022 Jun; 172(1):37-48. PubMed ID: 35471238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is resistance useless? Multidrug resistance and collateral sensitivity.
    Hall MD; Handley MD; Gottesman MM
    Trends Pharmacol Sci; 2009 Oct; 30(10):546-56. PubMed ID: 19762091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversal of multidrug resistance by Marsdenia tenacissima and its main active ingredients polyoxypregnanes.
    To KKW; Wu X; Yin C; Chai S; Yao S; Kadioglu O; Efferth T; Ye Y; Lin G
    J Ethnopharmacol; 2017 May; 203():110-119. PubMed ID: 28363522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ATP-dependent thermostabilization of human P-glycoprotein (ABCB1) is blocked by modulators.
    Lusvarghi S; Ambudkar SV
    Biochem J; 2019 Dec; 476(24):3737-3750. PubMed ID: 31774117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug-protein hydrogen bonds govern the inhibition of the ATP hydrolysis of the multidrug transporter P-glycoprotein.
    Chufan EE; Kapoor K; Ambudkar SV
    Biochem Pharmacol; 2016 Feb; 101():40-53. PubMed ID: 26686578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-Oxo-hexahydroquinoline derivatives as modulators of P-gp, MRP1 and BCRP transporters to overcome multidrug resistance in cancer cells.
    Ranjbar S; Khonkarn R; Moreno A; Baubichon-Cortay H; Miri R; Khoshneviszadeh M; Saso L; Edraki N; Falson P; Firuzi O
    Toxicol Appl Pharmacol; 2019 Jan; 362():136-149. PubMed ID: 30391378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of αvβ6 downregulates P-glycoprotein and sensitizes multidrug-resistant breast cancer cells to anticancer drugs.
    Zhang YH; Gao ZF; Dong GH; Li X; Wu Y; Li G; Wang AL; Li HL; Yin DL
    Neoplasma; 2020 Mar; 67(2):379-388. PubMed ID: 32039627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The critical size of gold nanoparticles for overcoming P-gp mediated multidrug resistance.
    Jiang Y; Wang Z; Duan W; Liu L; Si M; Chen X; Fang CJ
    Nanoscale; 2020 Aug; 12(31):16451-16461. PubMed ID: 32790812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.